{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:22:51Z","timestamp":1780582971328,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Clozapine is the treatment of choice in refractory psychosis. In most countries, clozapine must be stopped indefinitely if white blood cells fall below a defined threshold during routine monitoring. Despite evidence of severe adverse consequences of clozapine discontinuation, published accounts on the lived experiences and perspectives of patients and carers are scarce.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>We completed semi-structured interviews with patients (n\u2009=\u20094) and family carers (n\u2009=\u20094) on experiences of clozapine cessation following suspected drug-induced neutropenia. Interviews were audio-recorded, transcribed and analysed thematically.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The two overarching themes comprised:(i) stress of clozapine below threshold neutrophil results and (ii) patient and carer priorities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>There is a suggested need for evidence-based pharmacological and psychological approaches to support patients and carers after clozapine cessation. Such approaches will minimise the potentially negative physical and emotional sequela in the aftermath of a below threshold neutrophil result and reduce the likelihood of experiencing additional health and social inequalities after clozapine discontinuation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-023-04902-w","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T08:01:43Z","timestamp":1686211303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia"],"prefix":"10.1186","volume":"23","author":[{"given":"Ebenezer","family":"Oloyede","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Dunnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H","family":"MacCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eromona","family":"Whiskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Onwumere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"4902_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(22)00188-2","author":"E Oloyede","year":"2022","unstructured":"Oloyede E, Whiskey E, Casetta C, et al. Relaxation of the criteria for entry to the UK Clozapine Central Non-Rechallenge Database: a modelling study. The Lancet Psychiatry. 2022. https:\/\/doi.org\/10.1016\/S2215-0366(22)00188-2.","journal-title":"The Lancet Psychiatry"},{"key":"4902_CR2","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1017\/S204579602200066X","volume":"31","author":"E Oloyede","year":"2022","unstructured":"Oloyede E, Blackman G, Whiskey E, et al. Clozapine haematological monitoring for neutropenia: a global perspective. Epidemiol Psychiatric Sci. 2022;31:e83. https:\/\/doi.org\/10.1017\/S204579602200066X. 2022\/11\/25.","journal-title":"Epidemiol Psychiatric Sci"},{"key":"4902_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1017\/S0033291719000369","volume":"50","author":"L Xiao-Hong","year":"2020","unstructured":"Xiao-Hong L, Xiao-Mei Z, Lu L, et al. The prevalence of agranulocytosis and related death in clozapine-treated patients: a comprehensive meta-analysis of observational studies. Psychol Med. 2020;50:583\u201394.","journal-title":"Psychol Med"},{"key":"4902_CR4","doi-asserted-by":"publisher","unstructured":"Oloyede E, Casetta C, Dzahini O et al. There Is Life After the UK Clozapine Central Non-Rechallenge Database. Schizophr Bull 2021 2021\/02\/05. DOI: https:\/\/doi.org\/10.1093\/schbul\/sbab006.","DOI":"10.1093\/schbul\/sbab006"},{"key":"4902_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/YIC.0000000000000258","volume":"34","author":"E Whiskey","year":"2019","unstructured":"Whiskey E, Dzahini O, Ramsay R, et al. Need to bleed? Clozapine haematological monitoring approaches a time for change. Int Clin Psychopharmacol. 2019;34:264\u20138.","journal-title":"Int Clin Psychopharmacol"},{"key":"4902_CR6","doi-asserted-by":"publisher","first-page":"0","DOI":"10.4088\/JCP.16m11152","volume":"78","author":"RS Sultan","year":"2017","unstructured":"Sultan RS, Olfson M, Correll CU, et al. Evaluating the effect of the changes in FDA guidelines for clozapine monitoring. J Clin Psychiatry. 2017;78:0\u20130.","journal-title":"J Clin Psychiatry"},{"key":"4902_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.schres.2016.05.002","volume":"174","author":"SE Legge","year":"2016","unstructured":"Legge SE, Hamshere M, Hayes RD, et al. Reasons for discontinuing clozapine: a cohort study of patients commencing treatment. Schizophr Res. 2016;174:113\u20139. https:\/\/doi.org\/10.1016\/j.schres.2016.05.002. 2016\/05\/19.","journal-title":"Schizophr Res"},{"key":"4902_CR8","doi-asserted-by":"publisher","first-page":"204512532110320","DOI":"10.1177\/20451253211032053","volume":"11","author":"G Blackman","year":"2021","unstructured":"Blackman G, Oloyede E. Clozapine discontinuation withdrawal symptoms in schizophrenia. Therapeutic Adv Psychopharmacol. 2021;11:20451253211032053. https:\/\/doi.org\/10.1177\/20451253211032053.","journal-title":"Therapeutic Adv Psychopharmacol"},{"key":"4902_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbab103","author":"G Blackman","year":"2021","unstructured":"Blackman G, Oloyede E, Horowitz M, et al. Reducing the risk of withdrawal symptoms and relapse following Clozapine Discontinuation\u2014Is it feasible to develop evidence-based guidelines? Schizophr Bull. 2021. https:\/\/doi.org\/10.1093\/schbul\/sbab103.","journal-title":"Schizophr Bull"},{"key":"4902_CR10","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1186\/s12888-021-03514-6","volume":"21","author":"E Oloyede","year":"2021","unstructured":"Oloyede E, Dzahini O, Barnes N, et al. Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitals. BMC Psychiatry. 2021;21:502. https:\/\/doi.org\/10.1186\/s12888-021-03514-6.","journal-title":"BMC Psychiatry"},{"key":"4902_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41380-018-0335-7","volume":"24","author":"SE Legge","year":"2019","unstructured":"Legge SE, Pardi\u00f1as AF, Helthuis M, et al. A genome-wide association study in individuals of african ancestry reveals the importance of the Duffy-null genotype in the assessment of clozapine-related neutropenia. Mol Psychiatry. 2019;24:328\u201337. 2019\/01\/15.","journal-title":"Mol Psychiatry"},{"key":"4902_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/schizbullopen\/sgac042","author":"S Parkes","year":"2022","unstructured":"Parkes S, Mantell B, Oloyede E, et al. Patients\u2019 Experiences of Clozapine for treatment-resistant Schizophrenia: a systematic review. Schizophrenia Bull Open. 2022. https:\/\/doi.org\/10.1093\/schizbullopen\/sgac042.","journal-title":"Schizophrenia Bull Open"},{"key":"4902_CR13","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s11135-021-01182-y","volume":"56","author":"D Byrne","year":"2022","unstructured":"Byrne D. A worked example of Braun and Clarke\u2019s approach to reflexive thematic analysis. Qual Quant. 2022;56:1391\u2013412.","journal-title":"Qual Quant"},{"key":"4902_CR14","unstructured":"Clarke V, Braun V. Successful qualitative research: a practical guide for beginners. Success Qualitative Res 2013: 1\u2013400."},{"key":"4902_CR15","doi-asserted-by":"crossref","unstructured":"Peters S. Qualitative research methods in mental health. Royal Coll Psychiatrists, 2010, p. 35\u201340.","DOI":"10.1136\/ebmh.13.2.35"},{"key":"4902_CR16","first-page":"1753","volume":"26","author":"K Malterud","year":"2016","unstructured":"Malterud K, Siersma V, Guassora A. Sample size in qualitative interview studies. Qualitative Health Research. Sage Journals. 2016;26:1753\u201360.","journal-title":"Sage Journals"},{"key":"4902_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/14780887.2020.1769238","volume":"18","author":"V Braun","year":"2021","unstructured":"Braun V, Clarke V. One size fits all? What counts as quality practice in (reflexive) thematic analysis? Qualitative Res Psychol. 2021;18:328\u201352. https:\/\/doi.org\/10.1080\/14780887.2020.1769238.","journal-title":"Qualitative Res Psychol"},{"key":"4902_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3:77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qualitative Res Psychol"},{"key":"4902_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/160940690200100202","volume":"1","author":"JM Morse","year":"2002","unstructured":"Morse JM, Barrett M, Mayan M, et al. Verification strategies for establishing reliability and validity in qualitative research. Int J qualitative methods. 2002;1:13\u201322.","journal-title":"Int J qualitative methods"},{"key":"4902_CR20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/1077800410383121","volume":"16","author":"SJ Tracy","year":"2010","unstructured":"Tracy SJ. Qualitative quality: eight \u201cbig-tent\u201d criteria for excellent qualitative research. Qualitative Inq. 2010;16:837\u201351.","journal-title":"Qualitative Inq"},{"key":"4902_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/01.psy.0000116755.71033.10","volume":"66","author":"SC Palmer","year":"2004","unstructured":"Palmer SC, Kagee A, Coyne JC, et al. Experience of trauma, distress, and posttraumatic stress disorder among breast cancer patients. Psychosom Med. 2004;66:258\u201364.","journal-title":"Psychosom Med"},{"key":"4902_CR22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1017\/s0033291719000369","volume":"50","author":"X-H Li","year":"2020","unstructured":"Li X-H, Zhong X-M, Lu L, et al. The prevalence of agranulocytosis and related death in clozapine-treated patients: a comprehensive meta-analysis of observational studies. Psychol Med. 2020;50:583\u201394. https:\/\/doi.org\/10.1017\/s0033291719000369.","journal-title":"Psychol Med"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-04902-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-023-04902-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-04902-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T08:02:44Z","timestamp":1686211364000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-023-04902-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4902"],"URL":"https:\/\/doi.org\/10.1186\/s12888-023-04902-w","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"3 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving human subjects\/patients were approved by the South London and Maudsley NHS Foundation Trust Drugs and Therapeutic Committee (Approval number: DTC\/2022\/35). Informed consent was obtained from all subjects and\/or their legal guardian(s). The interviews were recorded for transcription with the participants\u2019 agreement and all data from the interviews were handled confidentially. The interview data were anonymized before being presented in the results, in such a way that no individual can be identified.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"413"}}